Milligan Sandra 4
4 · Organon & Co. · Filed May 3, 2023
Insider Transaction Report
Form 4
Milligan Sandra
Head of Research & Development
Transactions
- Tax Payment
Common Stock
2023-05-01$24.63/sh−826$20,344→ 25,783 total - Exercise/Conversion
Common Stock
2023-05-01+1,899→ 26,609 total - Exercise/Conversion
Restricted Stock Units
2023-05-01−1,899→ 0 totalFrom: 2023-05-01Exp: 2023-05-01→ Common Stock (1,899 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested.